Results 281 to 290 of about 49,735 (302)

IVIG and Derivatives

2007
Elizabeth E. Culler, Lennart E. Lögdberg   +1 more
openaire   +1 more source

Use of intravenous immunoglobulin G (IVIG)

Best Practice and Research in Clinical Haematology, 2006
R John Looney
exaly  

IVIg for GBS

Neurology, 1993
openaire   +1 more source

67-P: C1q-IVIG assay predicts IVIG efficacy in vivo

Human Immunology, 2009
G. Chen, F. Sequeira, D. Tyan
openaire   +1 more source

Impact of IVIG therapy on serologic testing for infectious diseases

Diagnostic Microbiology and Infectious Disease, 2020
George R Thompson, Wesley J Hoffmann, Stuart M Cohen   +2 more
exaly  

Indications for IVIG in rheumatic diseases.

Rheumatology, 2015
Ben Mulhearn, Ian Bruce
exaly  

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1

European Journal of Immunology, 2012
Georg Schett, Falk Nimmerjahn, Gerhard Krönke   +2 more
exaly  

Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity

Journal of Neurology, 2019
Markus Kinner, Thomas Grüter, Wolfgang Meyer   +2 more
exaly  

IVIG monitoring: a comparison of the effects IVIG has on methods for detecting alloantibodies

Human Immunology, 2002
Robert F McAlack, Deborah A Sesok-Pizzini, David H Lee, Nathan Burvainis, Charles Biondo, Danielle Cervellini   +5 more
openaire   +1 more source

Different Gm allotype amounts in human intravenous immunoglobulin (IVIG) preparations; survival of foreign Gm allotypes in immunodeficient patients

Clinical and Experimental Immunology, 2003
V -A Oxelius, M M Eibl
exaly